OR51E2 and prostate carcinoma: In the same vein, Kerslake et al. recently demonstrated that OR51E2 is upregulated in prostate adenocarcinoma and by using the GeneMANIA software, they found that this OR interacts with a wide range of genes associated with prostate cancer, such as kallikrein 3, anoctamin 7, arrestin β2, and serine/threonine kinase 3 [28].